Compile Data Set for Download or QSAR
Report error Found 55 Enz. Inhib. hit(s) with all data for entry = 50014096 Sort by
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 7nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 7nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138237(3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138236(2-Hexyloxy-5-imidazol-1-yl-pyridine | CHEMBL320105)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138236(2-Hexyloxy-5-imidazol-1-yl-pyridine | CHEMBL320105)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138233(2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138232(2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine | CHEMB...)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138238(4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138237(3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138233(2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138238(4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138231(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...)
Affinity DataIC50: 91nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 96nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138238(4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 101nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138232(2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine | CHEMB...)
Affinity DataIC50: 120nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138233(2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 129nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138232(2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine | CHEMB...)
Affinity DataIC50: 130nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138237(3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 185nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138233(2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 252nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138238(4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 344nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 348nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138231(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...)
Affinity DataIC50: 399nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138234([3-(4-Imidazol-1-yl-phenoxy)-propyl]-dimethyl-amin...)
Affinity DataIC50: 400nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138235([6-(4-Imidazol-1-yl-phenoxy)-hexyl]-dimethyl-amine...)
Affinity DataIC50: 410nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138237(3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 417nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 460nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138239(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-piperazine-1...)
Affinity DataIC50: 469nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138233(2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 620nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138232(2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine | CHEMB...)
Affinity DataIC50: 630nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138235([6-(4-Imidazol-1-yl-phenoxy)-hexyl]-dimethyl-amine...)
Affinity DataIC50: 800nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138236(2-Hexyloxy-5-imidazol-1-yl-pyridine | CHEMBL320105)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138232(2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine | CHEMB...)
Affinity DataIC50: 1.04E+3nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138238(4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 1.04E+3nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138240([2-(4-Imidazol-1-yl-phenoxy)-ethyl]-dimethyl-amine...)
Affinity DataIC50: 1.05E+3nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138237(3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138239(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-piperazine-1...)
Affinity DataIC50: 1.44E+3nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138231(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...)
Affinity DataIC50: 1.48E+3nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138231(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...)
Affinity DataIC50: 1.81E+3nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138239(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-piperazine-1...)
Affinity DataIC50: 2.24E+3nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138240([2-(4-Imidazol-1-yl-phenoxy)-ethyl]-dimethyl-amine...)
Affinity DataIC50: 2.96E+3nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138239(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-piperazine-1...)
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of cytochrome P450 2D6More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138234([3-(4-Imidazol-1-yl-phenoxy)-propyl]-dimethyl-amin...)
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138235([6-(4-Imidazol-1-yl-phenoxy)-hexyl]-dimethyl-amine...)
Affinity DataIC50: 4.46E+3nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138231(4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine |...)
Affinity DataIC50: 5.67E+3nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138235([6-(4-Imidazol-1-yl-phenoxy)-hexyl]-dimethyl-amine...)
Affinity DataIC50: 6.22E+3nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138234([3-(4-Imidazol-1-yl-phenoxy)-propyl]-dimethyl-amin...)
Affinity DataIC50: 9.70E+3nMAssay Description:Inhibition of cytochrome P450 2C19More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138240([2-(4-Imidazol-1-yl-phenoxy)-ethyl]-dimethyl-amine...)
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of cytochrome P450 1A2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138234([3-(4-Imidazol-1-yl-phenoxy)-propyl]-dimethyl-amin...)
Affinity DataIC50: 3.28E+4nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138235([6-(4-Imidazol-1-yl-phenoxy)-hexyl]-dimethyl-amine...)
Affinity DataIC50: 3.32E+4nMAssay Description:Inhibition of cytochrome P450 2C9More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50138234([3-(4-Imidazol-1-yl-phenoxy)-propyl]-dimethyl-amin...)
Affinity DataIC50: 3.90E+4nMAssay Description:Inhibition of cytochrome P450 3A4More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: